Sign up to save your podcasts
Or
Share Improving diversity in clinical drug trials
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Improving diversity in clinical drug trials
Erika is joined by Quintin Maidment, a vice president at CTRx Pathways, to discuss why diversity is critical in clinical drug trials and what barriers stand in the way. In the Beyond the News segment, Nick and Shawn discuss the controversy around efforts by Johnson & Johnson to create a rebate program around 340B drug pricing.
View all episodes
By HFMA
4.2
4141 ratings
Erika is joined by Quintin Maidment, a vice president at CTRx Pathways, to discuss why diversity is critical in clinical drug trials and what barriers stand in the way. In the Beyond the News segment, Nick and Shawn discuss the controversy around efforts by Johnson & Johnson to create a rebate program around 340B drug pricing.
More shows like HFMA’s Voices in Healthcare Finance
View all
WSJ Tech News Briefing
1,636 Listeners
WSJ What’s News
4,302 Listeners
WSJ Your Money Briefing
1,746 Listeners
Coaching for Leaders
1,487 Listeners
The Hospital Finance Podcast
37 Listeners
How to Be Awesome at Your Job
1,051 Listeners
WSJ Minute Briefing
654 Listeners
KFF Health News' 'What the Health?'
469 Listeners
Wall Street Breakfast
1,008 Listeners
Becker’s Healthcare Podcast
178 Listeners
Tradeoffs
383 Listeners
The Prof G Pod with Scott Galloway
4,951 Listeners
A Bit of Optimism
2,174 Listeners
ReThinking
602 Listeners
Healthcare Blame Game
6 Listeners
HBR On Leadership
135 Listeners